Daily Archives: September 20, 2022

Greater Transplant-free Survival in Patients Receiving Obeticholic Acid for Primary Biliary Cholangitis in a Clinical Trial Setting Compared to Real-World External Controls

Posted on September 20, 2022 by Gastroenterology Journal

The POISE randomized double-blind placebo-controlled trial demonstrated that obeticholic acid (OCA) reduced biomarkers associated with adverse clinical outcomes (ALP, bilirubin, AST, ALT) in patients with primary biliary cholangitis (PBC). The objectiv… Continue reading →

Posted in News | Comments Off on Greater Transplant-free Survival in Patients Receiving Obeticholic Acid for Primary Biliary Cholangitis in a Clinical Trial Setting Compared to Real-World External Controls

A Tale of Two Fibres: a Liver Twist!

Posted on September 20, 2022 by Gastroenterology Journal
Posted in News | Comments Off on A Tale of Two Fibres: a Liver Twist!